West Pharmaceutical Services, Inc.WSTNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.64% |
| Q3 2025 | 6.22% |
| Q2 2025 | 46.77% |
| Q1 2025 | -30.98% |
| Q4 2024 | -4.34% |
| Q3 2024 | 22.19% |
| Q2 2024 | -3.47% |
| Q1 2024 | -15.84% |
| Q4 2023 | -15.07% |
| Q3 2023 | 4.00% |
| Q2 2023 | 10.79% |
| Q1 2023 | 35.92% |
| Q4 2022 | -14.59% |
| Q3 2022 | -36.02% |
| Q2 2022 | 8.46% |
| Q1 2022 | 17.67% |
| Q4 2021 | -15.89% |
| Q3 2021 | -6.25% |
| Q2 2021 | 23.88% |
| Q1 2021 | 53.66% |
| Q4 2020 | 19.56% |
| Q3 2020 | -9.76% |
| Q2 2020 | 22.75% |
| Q1 2020 | 16.28% |
| Q4 2019 | 13.50% |
| Q3 2019 | -14.83% |
| Q2 2019 | 19.31% |
| Q1 2019 | 6.54% |
| Q4 2018 | -5.80% |
| Q3 2018 | -1.60% |
| Q2 2018 | 28.67% |
| Q1 2018 | 1844.00% |
| Q4 2017 | -104.90% |
| Q3 2017 | 31.44% |
| Q2 2017 | -36.29% |
| Q1 2017 | 55.75% |
| Q4 2016 | 3.99% |
| Q3 2016 | -15.88% |
| Q2 2016 | 102.26% |
| Q1 2016 | -33.83% |